核细胞蛋白6作为结直肠癌的潜在瘤原因子
Shunxin Song1,2,3, Yixin Zhang1,2,3, Lingxi Li2
1Department of General Surgery, The First People's Hospital of Chenzhou, University of South China, Chenzhou, People's Republic of China.
PloS one
|February 2, 2026
概括
核蛋白6 (NOL6) 作为结直肠癌 (CRC) 的瘤基因,促进细胞增殖和瘤生长. 针对NOL6提供了一种潜在的治疗策略,可以改善CRC管理和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 大肠直肠癌 (CRC) 带来了显著的死亡率和侵入性挑战.
- 了解CRC监管机制对于推进治疗至关重要.
- 对于早期的CRC诊断,需要用于细胞增殖的新生物标志物.
研究的目的:
- 研究核蛋白6 (NOL6) 作为CRC细胞增殖的潜在生物标志物.
- 探索NOL6在CRC进展和瘤发生中的作用.
- 确定用于CRC管理的治疗目标.
主要方法:
- 定量实时PCR和NOL6表达的免疫组织化学.
- 在体外测定 (MTT,Celigo,殖民地形成,流细胞计,transwell) 细胞增殖,细胞亡,迁移和入侵.
- 蛋白质组和转录组分析 (TMT,西方涂抹) 以确定下游目标.
- 异种移植小鼠模型以评估体内瘤生长.
主要成果:
- 与正常组织相比,NOL6在CRC组织中显著上调.
- 低调NOL6降低了CRC细胞的增殖,殖民地形成和瘤生长 in vivo.
- 在NOL6 Knockdown中增加了CRC细胞的亡,并抑制了MCM3/MCM7的表达.
- 降低NOL6 knockdown降低了CRC细胞迁移和入侵.
结论:
- NOL6作为一种促进CRC进展的瘤基因起作用.
- NOL6是CRC管理的潜在治疗点.
- NOL6可以作为CRC细胞增殖的新生物标志物.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
559
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
559
Factors Affecting Protein-Drug Binding: Drug-Related Factors
485
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485
Factors Affecting Protein-Drug Binding: Patient-Related Factors
325
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
325
Transcription Factors
82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Factors Affecting Protein-Drug Binding: Drug Interactions
603
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
603


